At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
the second-generation MCCGdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Second-generation Versus First-generation Magnetically Controlled Capsule Gastroscopy for Upper Gastrointestinal Tract: a Randomized Controlled Clinical Trial.
In Brief
A clinical study evaluating the second-generation MCCG for Capsule Endoscopy. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The aim of this study is to evaluate the clinical application of the second-generation MCCG with higher image resolution and frame rate for upper gastrointestinal tract compared with the first-generation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCapsule Endoscopy
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartMay 2019
First PostedJun 2019
Primary CompletionJul 2019
Study CompletionJul 2019
TodayJul 2026
First PostedJun 6, 2019
Enrollment StartMay 10, 2019
Primary CompletionJul 18, 2019
Study CompletionJul 25, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.1 years ago
Interventions
the second-generation MCCGdevice
Patients in the experimental group swallowed the second-generation MCCG (Ankon Navicam-2).